REFERENCES
- Błaszczak-Świątkiewicz , K. ; Mikiciuk-Olasik , E. Role of Hipoxia in Advances in New Anticancer Diagnostics and Therapy . Wiadomości Chemiczne 2008 , 62 ( 11–12 ), 1066 – 1089 .
- Denny , W. A. The Role of Hypoxia-Activated Prodrugs in Cancer Therapy . Lancet Oncol. 2000 , 1 ( 1 ), 25 – 29 .
- Brown , J. M. The Hypoxic Cell: A Target for Selective Cancer Therapy . Cancer Res. 1999 , 59 , 5863 – 5870 .
- Jneg , L. A. ; Cosby , L. A. ; Shansky , C. W. ; Sartorelli , A. C. Potential Bioreductive Alkylating Agents. Benzoquinone Derivatives . J. Med. Chem. 1972 , 15 ( 12 ), 1247 – 1251 .
- Cowan , D. S. M. ; Matejovic , J. F. ; McClelland , R. A. ; Ruth , A. M. DNA-Targeted 2-Nitroimidazoles: In Vivo and In Vitro Studies . British J. Cancer 1994 , 70 , 1067 – 1074 .
- McKeown , S. R. ; Friery , O. P. ; McIntyre , I. A. ; Hejmadi , M. V. ; Paterson , L. H. ; Hirst , D. G. Evidence for Therapeutic Gain When AQ4 N or TPZ is Combined with Radiation . British J. Cancer 1996 , 74 , 39 – 42 .
- Selcen , A. A. ; Gunesl , H. S. ; Topcu , Z. 1H-Benzimidazole Derivatives as Mammalian DNA Topoisomerase I Inhibitors . Acta Biochim. Polonica 2007 , 54 ( 3 ), 561 – 565 .
- Koch , C. J. Unusual Oxygen Concentration Dependence of Toxicity of SR-4233, a Hypoxic Celltoxin . Cancer Res. 1993 , 53 , 3992 – 3997 .